![](/img/cover-not-exists.png)
Availability of irinotecan in a second-line setting confers survival benefit to patients with advanced gastric cancer refractory to fluoropyrimidine-based regimens
OBA, MASARU, CHIN, KEISHO, KAWAZOE, YOSHIMASA, TAKAGI, KOICHI, OGURA, MARIKO, SHINOZAKI, EIJI, SUENAGA, MITSUKUNI, MATSUSAKA, SATOSHI, MIZUNUMA, NOBUYUKI, HATAKE, KIYOHIKOVolume:
2
Language:
english
Journal:
Oncology Letters
DOI:
10.3892/ol.2011.241
Date:
March, 2011
File:
PDF, 279 KB
english, 2011